New

Human Liver Models Market

2021

Human Liver Models Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Liver Organoids, Liver-on-a-chip, 2D Models, 3D Bioprinting, and aOthers); Application (Educational, Drug Discovery, and Other); End User (Research Institutes, Pharmaceutical Companies, and Others) Geography

| Report Code: TIPRE00025128 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Market Insights

Human Liver Models Market 2028 By Type, Application, End User, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

The liver is an important organ that performs vital body functions such as synthesis of blood clotting factors, bile production, protein production, and detoxification. Human liver models are used to study the drug's toxicity and enable understanding of the effect of drugs and the progression of liver disease. The rising focus on developing alternatives for the animal testing models is one of the major factors estimated to encourage the growth of the global human liver models in the next few years.

MARKET SCOPE

The "Global Human Liver Models Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Human liver models market with detailed market segmentation by type, application, end use, and geography. The report provides key statistics on the market status of the leading Human liver models market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
  • Based on type, the global Human liver models market is segmented into liver organoids, liver-on-a-chip, 2d models, 3d bioprinting, others.
  • On the basis of application, the market is segmented into educational, drug discovery, other.
  • On the basis of end use, the market is segmented into research institutes, pharmaceutical companies, others.
MARKET DYNAMICS
Drivers
  • Rise in the incidences of liver diseases.
  • Rise in the geriatric population.
  • Increasing research and development in healthcare.
  • Increasing focus on developing alternatives for the animal-based models.
Restraints
  • The high cost of liver models and issues with the incorporation of liver models into existing workflow are the major restraining factor for this market.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Human liver models market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Human liver models market in these regions.

IMPACT OF COVID-19 ON HUMAN LIVER MODELS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS

The report covers key developments in the Human liver models market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Human liver models market are anticipated to lucrative growth opportunities in the future with the rising demand for Human liver models in the global market. 

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Human liver models market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  • THERMO FISHER SCIENTIFIC
  • EMULATE INC.
  • CN BIO INNOVATIONS
  • ORGANOVO HOLDINGS INC.
  • CYFUSE BIOMEDICAL K.K.
  • MIMETAS
  • Insphero
  • BIOIVT
  • CELLINK
  • KERAFAST    
The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study. 


Get more information on this report :

1. INTRODUCTION

1.1. SCOPE OF THE STUDY

1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

1.3. MARKET SEGMENTATION

1.3.1 Human Liver Models Market - By Type

1.3.2 Human Liver Models Market - By Application

1.3.3 Human Liver Models Market - By End User

1.3.4 Human Liver Models Market - By Region

1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. HUMAN LIVER MODELS MARKET LANDSCAPE

4.1. OVERVIEW

4.2. PEST ANALYSIS

4.2.1 North America - Pest Analysis

4.2.2 Europe - Pest Analysis

4.2.3 Asia-Pacific - Pest Analysis

4.2.4 Middle East and Africa - Pest Analysis

4.2.5 South and Central America - Pest Analysis

4.3. EXPERT OPINIONS

5. HUMAN LIVER MODELS MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS

5.2. KEY MARKET RESTRAINTS

5.3. KEY MARKET OPPORTUNITIES

5.4. FUTURE TRENDS

5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. HUMAN LIVER MODELS MARKET - GLOBAL MARKET ANALYSIS

6.1. HUMAN LIVER MODELS - GLOBAL MARKET OVERVIEW

6.2. HUMAN LIVER MODELS - GLOBAL MARKET AND FORECAST TO 2028

6.3. MARKET POSITIONING

7. HUMAN LIVER MODELS MARKET - REVENUE AND FORECASTS TO 2028 – TYPE

7.1. OVERVIEW

7.2. TYPE MARKET FORECASTS AND ANALYSIS

7.3. LIVER ORGANOIDS

7.3.1. Overview

7.3.2. Liver Organoids Market Forecast and Analysis

7.4. LIVER-ON-A-CHIP

7.4.1. Overview

7.4.2. Liver-on-a-chip Market Forecast and Analysis

7.5. 2D MODELS

7.5.1. Overview

7.5.2. 2D Models Market Forecast and Analysis

7.6. 3D BIOPRINTING

7.6.1. Overview

7.6.2. 3D Bioprinting Market Forecast and Analysis

7.7. OTHERS

7.7.1. Overview

7.7.2. Others Market Forecast and Analysis

8. HUMAN LIVER MODELS MARKET - REVENUE AND FORECASTS TO 2028 – APPLICATION

8.1. OVERVIEW

8.2. APPLICATION MARKET FORECASTS AND ANALYSIS

8.3. EDUCATIONAL

8.3.1. Overview

8.3.2. Educational Market Forecast and Analysis

8.4. DRUG DISCOVERY

8.4.1. Overview

8.4.2. Drug Discovery Market Forecast and Analysis

8.5. OTHER

8.5.1. Overview

8.5.2. Other Market Forecast and Analysis

9. HUMAN LIVER MODELS MARKET - REVENUE AND FORECASTS TO 2028 – END USER

9.1. OVERVIEW

9.2. END USER MARKET FORECASTS AND ANALYSIS

9.3. RESEARCH INSTITUTES

9.3.1. Overview

9.3.2. Research Institutes Market Forecast and Analysis

9.4. PHARMACEUTICAL COMPANIES

9.4.1. Overview

9.4.2. Pharmaceutical Companies Market Forecast and Analysis

9.5. OTHERS

9.5.1. Overview

9.5.2. Others Market Forecast and Analysis

10. HUMAN LIVER MODELS MARKET REVENUE AND FORECASTS TO 2028 – GEOGRAPHICAL ANALYSIS

10.1. NORTH AMERICA

10.1.1 North America Human Liver Models Market Overview

10.1.2 North America Human Liver Models Market Forecasts and Analysis

10.1.3 North America Human Liver Models Market Forecasts and Analysis - By Type

10.1.4 North America Human Liver Models Market Forecasts and Analysis - By Application

10.1.5 North America Human Liver Models Market Forecasts and Analysis - By End User

10.1.6 North America Human Liver Models Market Forecasts and Analysis - By Countries

10.1.6.1 United States Human Liver Models Market

10.1.6.1.1 United States Human Liver Models Market by Type

10.1.6.1.2 United States Human Liver Models Market by Application

10.1.6.1.3 United States Human Liver Models Market by End User

10.1.6.2 Canada Human Liver Models Market

10.1.6.2.1 Canada Human Liver Models Market by Type

10.1.6.2.2 Canada Human Liver Models Market by Application

10.1.6.2.3 Canada Human Liver Models Market by End User

10.1.6.3 Mexico Human Liver Models Market

10.1.6.3.1 Mexico Human Liver Models Market by Type

10.1.6.3.2 Mexico Human Liver Models Market by Application

10.1.6.3.3 Mexico Human Liver Models Market by End User

10.2. EUROPE

10.2.1 Europe Human Liver Models Market Overview

10.2.2 Europe Human Liver Models Market Forecasts and Analysis

10.2.3 Europe Human Liver Models Market Forecasts and Analysis - By Type

10.2.4 Europe Human Liver Models Market Forecasts and Analysis - By Application

10.2.5 Europe Human Liver Models Market Forecasts and Analysis - By End User

10.2.6 Europe Human Liver Models Market Forecasts and Analysis - By Countries

10.2.6.1 Germany Human Liver Models Market

10.2.6.1.1 Germany Human Liver Models Market by Type

10.2.6.1.2 Germany Human Liver Models Market by Application

10.2.6.1.3 Germany Human Liver Models Market by End User

10.2.6.2 France Human Liver Models Market

10.2.6.2.1 France Human Liver Models Market by Type

10.2.6.2.2 France Human Liver Models Market by Application

10.2.6.2.3 France Human Liver Models Market by End User

10.2.6.3 Italy Human Liver Models Market

10.2.6.3.1 Italy Human Liver Models Market by Type

10.2.6.3.2 Italy Human Liver Models Market by Application

10.2.6.3.3 Italy Human Liver Models Market by End User

10.2.6.4 Spain Human Liver Models Market

10.2.6.4.1 Spain Human Liver Models Market by Type

10.2.6.4.2 Spain Human Liver Models Market by Application

10.2.6.4.3 Spain Human Liver Models Market by End User

10.2.6.5 United Kingdom Human Liver Models Market

10.2.6.5.1 United Kingdom Human Liver Models Market by Type

10.2.6.5.2 United Kingdom Human Liver Models Market by Application

10.2.6.5.3 United Kingdom Human Liver Models Market by End User

10.2.6.6 Russia Human Liver Models Market

10.2.6.6.1 Russia Human Liver Models Market by Type

10.2.6.6.2 Russia Human Liver Models Market by Application

10.2.6.6.3 Russia Human Liver Models Market by End User

10.3. ASIA-PACIFIC

10.3.1 Asia-Pacific Human Liver Models Market Overview

10.3.2 Asia-Pacific Human Liver Models Market Forecasts and Analysis

10.3.3 Asia-Pacific Human Liver Models Market Forecasts and Analysis - By Type

10.3.4 Asia-Pacific Human Liver Models Market Forecasts and Analysis - By Application

10.3.5 Asia-Pacific Human Liver Models Market Forecasts and Analysis - By End User

10.3.6 Asia-Pacific Human Liver Models Market Forecasts and Analysis - By Countries

10.3.6.1 Australia Human Liver Models Market

10.3.6.1.1 Australia Human Liver Models Market by Type

10.3.6.1.2 Australia Human Liver Models Market by Application

10.3.6.1.3 Australia Human Liver Models Market by End User

10.3.6.2 China Human Liver Models Market

10.3.6.2.1 China Human Liver Models Market by Type

10.3.6.2.2 China Human Liver Models Market by Application

10.3.6.2.3 China Human Liver Models Market by End User

10.3.6.3 India Human Liver Models Market

10.3.6.3.1 India Human Liver Models Market by Type

10.3.6.3.2 India Human Liver Models Market by Application

10.3.6.3.3 India Human Liver Models Market by End User

10.3.6.4 Japan Human Liver Models Market

10.3.6.4.1 Japan Human Liver Models Market by Type

10.3.6.4.2 Japan Human Liver Models Market by Application

10.3.6.4.3 Japan Human Liver Models Market by End User

10.3.6.5 South Korea Human Liver Models Market

10.3.6.5.1 South Korea Human Liver Models Market by Type

10.3.6.5.2 South Korea Human Liver Models Market by Application

10.3.6.5.3 South Korea Human Liver Models Market by End User

10.3.6.6 Rest of Asia-Pacific Human Liver Models Market

10.3.6.6.1 Rest of Asia-Pacific Human Liver Models Market by Type

10.3.6.6.2 Rest of Asia-Pacific Human Liver Models Market by Application

10.3.6.6.3 Rest of Asia-Pacific Human Liver Models Market by End User

10.4. MIDDLE EAST AND AFRICA

10.4.1 Middle East and Africa Human Liver Models Market Overview

10.4.2 Middle East and Africa Human Liver Models Market Forecasts and Analysis

10.4.3 Middle East and Africa Human Liver Models Market Forecasts and Analysis - By Type

10.4.4 Middle East and Africa Human Liver Models Market Forecasts and Analysis - By Application

10.4.5 Middle East and Africa Human Liver Models Market Forecasts and Analysis - By End User

10.4.6 Middle East and Africa Human Liver Models Market Forecasts and Analysis - By Countries

10.4.6.1 South Africa Human Liver Models Market

10.4.6.1.1 South Africa Human Liver Models Market by Type

10.4.6.1.2 South Africa Human Liver Models Market by Application

10.4.6.1.3 South Africa Human Liver Models Market by End User

10.4.6.2 Saudi Arabia Human Liver Models Market

10.4.6.2.1 Saudi Arabia Human Liver Models Market by Type

10.4.6.2.2 Saudi Arabia Human Liver Models Market by Application

10.4.6.2.3 Saudi Arabia Human Liver Models Market by End User

10.4.6.3 U.A.E Human Liver Models Market

10.4.6.3.1 U.A.E Human Liver Models Market by Type

10.4.6.3.2 U.A.E Human Liver Models Market by Application

10.4.6.3.3 U.A.E Human Liver Models Market by End User

10.4.6.4 Rest of Middle East and Africa Human Liver Models Market

10.4.6.4.1 Rest of Middle East and Africa Human Liver Models Market by Type

10.4.6.4.2 Rest of Middle East and Africa Human Liver Models Market by Application

10.4.6.4.3 Rest of Middle East and Africa Human Liver Models Market by End User

10.5. SOUTH AND CENTRAL AMERICA

10.5.1 South and Central America Human Liver Models Market Overview

10.5.2 South and Central America Human Liver Models Market Forecasts and Analysis

10.5.3 South and Central America Human Liver Models Market Forecasts and Analysis - By Type

10.5.4 South and Central America Human Liver Models Market Forecasts and Analysis - By Application

10.5.5 South and Central America Human Liver Models Market Forecasts and Analysis - By End User

10.5.6 South and Central America Human Liver Models Market Forecasts and Analysis - By Countries

10.5.6.1 Brazil Human Liver Models Market

10.5.6.1.1 Brazil Human Liver Models Market by Type

10.5.6.1.2 Brazil Human Liver Models Market by Application

10.5.6.1.3 Brazil Human Liver Models Market by End User

10.5.6.2 Argentina Human Liver Models Market

10.5.6.2.1 Argentina Human Liver Models Market by Type

10.5.6.2.2 Argentina Human Liver Models Market by Application

10.5.6.2.3 Argentina Human Liver Models Market by End User

10.5.6.3 Rest of South and Central America Human Liver Models Market

10.5.6.3.1 Rest of South and Central America Human Liver Models Market by Type

10.5.6.3.2 Rest of South and Central America Human Liver Models Market by Application

10.5.6.3.3 Rest of South and Central America Human Liver Models Market by End User

11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HUMAN LIVER MODELS MARKET

11.1 North America

11.2 Europe

11.3 Asia-Pacific

11.4 Middle East and Africa

11.5 South and Central America

12. INDUSTRY LANDSCAPE

12.1. MERGERS AND ACQUISITIONS

12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES

12.3. NEW PRODUCT LAUNCHES

12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. HUMAN LIVER MODELS MARKET, KEY COMPANY PROFILES

13.1. THERMO FISHER SCIENTIFIC

13.1.1. Key Facts

13.1.2. Business Description

13.1.3. Products and Services

13.1.4. Financial Overview

13.1.5. SWOT Analysis

13.1.6. Key Developments

13.2. EMULATE INC.

13.2.1. Key Facts

13.2.2. Business Description

13.2.3. Products and Services

13.2.4. Financial Overview

13.2.5. SWOT Analysis

13.2.6. Key Developments

13.3. CN BIO INNOVATIONS

13.3.1. Key Facts

13.3.2. Business Description

13.3.3. Products and Services

13.3.4. Financial Overview

13.3.5. SWOT Analysis

13.3.6. Key Developments

13.4. ORGANOVO HOLDINGS INC.

13.4.1. Key Facts

13.4.2. Business Description

13.4.3. Products and Services

13.4.4. Financial Overview

13.4.5. SWOT Analysis

13.4.6. Key Developments

13.5. CYFUSE BIOMEDICAL K.K.

13.5.1. Key Facts

13.5.2. Business Description

13.5.3. Products and Services

13.5.4. Financial Overview

13.5.5. SWOT Analysis

13.5.6. Key Developments

13.6. MIMETAS

13.6.1. Key Facts

13.6.2. Business Description

13.6.3. Products and Services

13.6.4. Financial Overview

13.6.5. SWOT Analysis

13.6.6. Key Developments

13.7. INSPHERO

13.7.1. Key Facts

13.7.2. Business Description

13.7.3. Products and Services

13.7.4. Financial Overview

13.7.5. SWOT Analysis

13.7.6. Key Developments

13.8. BIOIVT

13.8.1. Key Facts

13.8.2. Business Description

13.8.3. Products and Services

13.8.4. Financial Overview

13.8.5. SWOT Analysis

13.8.6. Key Developments

13.9. CELLINK

13.9.1. Key Facts

13.9.2. Business Description

13.9.3. Products and Services

13.9.4. Financial Overview

13.9.5. SWOT Analysis

13.9.6. Key Developments

13.10. KERAFAST

13.10.1. Key Facts

13.10.2. Business Description

13.10.3. Products and Services

13.10.4. Financial Overview

13.10.5. SWOT Analysis

13.10.6. Key Developments

13.11. CYPRIO

13.11.1. Key Facts

13.11.2. Business Description

13.11.3. Products and Services

13.11.4. Financial Overview

13.11.5. SWOT Analysis

13.11.6. Key Developments

13.12. KIRKSTALL

13.12.1. Key Facts

13.12.2. Business Description

13.12.3. Products and Services

13.12.4. Financial Overview

13.12.5. SWOT Analysis

13.12.6. Key Developments

14. APPENDIX

14.1. ABOUT THE INSIGHT PARTNERS

14.2. GLOSSARY OF TERMS

The List of Companies
  1. THERMO FISHER SCIENTIFIC
  2. EMULATE INC.
  3. CN BIO INNOVATIONS
  4. ORGANOVO HOLDINGS INC.
  5. CYFUSE BIOMEDICAL K.K.
  6. MIMETAS
  7. Insphero
  8. BIOIVT
  9. CELLINK
  10. KERAFAST
  11. CYPRIO
  12. KIRKSTALL
TIPRE00025128
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.